Want to join the conversation?
$CSCO's 2Q16 revenue from Americas fell by $0.2Bil vs. 2Q15, mainly due to the sale of SP Video CPE Business. Revenue in APJC grew $0.2Bil, led by product revenue growth in China. EMEA revenue was flat. The company said that the BRICM countries experienced product revenue growth of 15% in 2Q16, despite lower product revenue in Brazil and Russia.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?